FOXM1 and neoplasm: Several studies have reported FOXM1 overexpression in human PDA cell lines and tumor specimens, as well as a correlation with clinical phenotype, lymph node metastasis, histological differentiation and poor survival [49,50,52], suggesting FOXM1 expression as a biomarker to predict the clinical outcome of PDA patients.